Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1481 of 6351
-
Can acupuncture boost lung cancer treatment? new trial aims to find out
Disease control Recruiting nowThis multicentre, randomized controlled trial evaluates the effect and safety of acupuncture combing with PD-1 inhibitors plus chemotherapy in NSCLC. Participants will be randomly assigned to undergo either acupuncture or sham acupuncture concurrent with the initial four-six cycl…
Sponsor: Guangzhou University of Traditional Chinese Medicine • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Suspension training vs. standard therapy: which relieves back pain more?
Symptom relief CompletedThis study compared the effectiveness of suspension exercises based on the Neurac method with conventional physiotherapy in adults with chronic non-specific low back pain. The study evaluated changes in pain intensity, health-related quality of life, and functional performance fo…
Sponsor: Lebanese German University • Aim: Symptom relief
Last updated Sep 05, 2026 00:00 UTC
-
FitBit and coaching app aim to ease CAR-T side effects in landmark trial
Symptom relief Recruiting nowThe overall purpose of this randomized control trial (RCT) is to determine the clinical effect of a multilevel, RPM-enhanced intervention during and after completion of outpatient CAR-T therapy in 190 patients and their family caregivers (FCGs).
Phase 3 • Sponsor: City of Hope Medical Center • Aim: Symptom relief
Last updated Aug 30, 2026 00:00 UTC
-
New imaging study aims to stop blindness from misdiagnosed artery inflammation
Knowledge-focused Recruiting nowGiant cell arteritis (GCA) is an inflammation of the blood vessels. A dangerous complication is sudden vision loss due to insufficient blood supply to the optic nerve. However, it is often difficult to distinguish acute vision loss due to GCA from a similar condition of insuffici…
Sponsor: Rigshospitalet, Denmark • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Can an immune boost keep myeloma patients Infection-Free on powerful new drugs?
Disease control Recruiting nowMultiple myeloma is a cancer of the plasma cells in the bone marrow. The main aim of this study is to learn how well the Immune Globulin Infusion (human), 10 percentage (%) (IGI, 10%) can help prevent infections in participants with multiple myeloma receiving B-cell maturation a…
Phase 3 • Sponsor: Takeda • Aim: Disease control
Last updated Sep 10, 2026 01:00 UTC
-
Meth treatment study explores whether less use, not just no use, improves health
Disease control Recruiting nowReduced drug use is a clinically meaningful target for treatment development, but few studies have evaluated the positive impacts produced by this behavioral change, preventing adoption of this endpoint in clinical trials. The proposed research will fill that critical knowledge g…
Sponsor: William Stoops • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New shot aims to block tetanus after cuts and wounds
Prevention Recruiting nowStudy sites were selected from hospitals across diverse regions of China. Approximately 6,000 participants who require passive immunization against tetanus due to various injuries (including those with severe wounds or heavily contaminated injuries) will be enrolled per clinical …
Sponsor: Zhuhai Trinomab Pharmaceutical Co., Ltd. • Aim: Prevention
Last updated Jul 29, 2026 00:00 UTC
-
New hope for Hard-to-Treat cancers? first human trial launches
Disease control Recruiting nowA Phase I, First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of AT03-65 in Adults with Advanced Solid Tumors
Phase 1 • Sponsor: Axcynsis Therapeutics Pte Ltd • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Can a Vein-Blocking procedure ease chronic pelvic pain?
Symptom relief Recruiting nowPelvic congestion syndrome (PCS) is a common cause of chronic pelvic pain in women and is associated with pelvic venous insufficiency. This prospective interventional study aims to evaluate the safety and clinical effectiveness of endovascular embolization in relieving symptoms a…
Sponsor: Sohag University • Aim: Symptom relief
Last updated Jul 31, 2026 00:00 UTC
-
New cholesterol drug SHR-1918 enters final testing phase
Disease control Recruiting nowThe study is being conducted to evaluate the efficacy, and safety of SHR-1918 in reducing serum low-density lipoprotein cholesterol (LDL-C) and total triglycerides (TG) in patients with hyperlipidemia compared with placebo, and also includes To evaluate the effectiveness of SHR-1…
Phase 3 • Sponsor: Beijing Suncadia Pharmaceuticals Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New radiotherapy technique aims to cut prostate cancer treatment side effects
Symptom relief Recruiting nowThis prospective clinical study compares patient-reported outcome measures (PROMs) after adaptive or conventional radiotherapy in prostate cancer. Adaptive radiotherapy (ART) aims to reduce uncertainties related to daily anatomical variations, thereby improving treatment accuracy…
Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
New drug aims to speed platelet recovery in stem cell transplant patients
Disease control Recruiting nowThis study is an investigator-initiated prospective, single-center, open-label clinical trial designed to evaluate the clinical efficacy and safety of Lusutrombopag in promoting platelet remodeling after allogeneic hematopoietic stem cell transplantation in patients with hematolo…
Sponsor: The General Hospital of Western Theater Command • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New hope for advanced breast cancer: experimental drug targets resistant tumors
Disease control Stopped earlyThis is a first-in-human, Phase Ia/Ib, dose-escalation and expansion study evaluating the safety, pharmacokinetics, and activity of GDC-0587 (cyclin-dependent kinase-4 \[CDK4\] inhibitor) as a monotherapy and in combination with giredestrant in participants with locally advanced …
Phase 1 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Experimental CAR T-Cell therapy takes on Hard-to-Treat prostate cancer
Disease control Recruiting nowThis FTiH, single-arm, open-label, investigator-initiated Phase I trial will evaluate the safety, antitumour activity, CK/pharmacodynamics (PD), biomarkers, immunogenicity, and feasibility of A-CAR032 in adult participants with mCRPC, who have previously progressed after ARPI tre…
Phase 1 • Sponsor: Shanghai AbelZeta Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New injectable HIV prevention program aims to protect latine communities
Prevention Recruiting nowThe purpose of this project is to test a culturally-tailored, community-delivered long-acting injectable PrEP (lenacapavir) program for Latine gay and bisexual men (GBM) and transgender women (TGW). The objective is to evaluate whether this intervention demonstrates greater persi…
Phase 4 • Sponsor: Duke University • Aim: Prevention
Last updated Aug 28, 2026 00:00 UTC
-
Surgeons tailor Stent-Grafts to fix aortic aneurysms in new trial
Disease control Recruiting nowThe purpose of this study is to see if physician modified endovascular grafts (PMEG) can be used safely for the treatment of aortic disorders. The surgeon will modify a commercially available graft tailored to the participant's anatomy for surgery. The researchers will follow par…
Sponsor: Chandler Long, MD • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Can a smartphone app keep sickle cell patients out of the ER?
Disease control Recruiting nowIn a hybrid type I effectiveness-implementation trial, our three-center research teams aim to examine whether empowering adults with sickle cell disease (SCD) with patient-facing SCD-specific guidelines through an mHealth application with booklets will decrease acute healthcare u…
Sponsor: Ohio State University • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Could a new anesthesia method help very underweight lung transplant patients breathe on their own after surgery?
Disease control Not yet recruitingThe goal of this prospective, multicenter, single-arm clinical study is to learn whether a spontaneous breathing-preserving perioperative management strategy can improve recovery and is safe in lung transplant recipients with very low body weight (body mass index \[BMI\] \<16 kg/…
Sponsor: The First Affiliated Hospital of Guangzhou Medical University • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Community program aims to cut HIV risk in latino gay men
Prevention Recruiting nowThe goal of this quasi-experimental, community intervention is to reduce HIV sexual risk among Latino immigrant bisexual men or men who have sex with men. The main questions the study aims to answer are: Does the intervention improve sexual risk behaviors? Does the intervention …
Sponsor: San Francisco State University • Aim: Prevention
Last updated Jun 27, 2026 12:00 UTC
-
Broccoli vs. bladder cancer: could your diet keep tumors away?
Disease control Recruiting nowThis phase II trial is being done to develop and test a healthy eating program to reduce cancer recurrence (cancer that has come back after a period of improvement) and/or progression (cancer that is growing, spreading, or getting worse) in patients with non-muscle invasive bladd…
Phase 2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC